AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

2.010

-0.040-1.95%

Volume:415.17K

Turnover:829.32K

Market Cap:720.67M

PE:-11.76

High:2.030

Open:2.030

Low:1.955

Close:2.050

52wk High:2.250

52wk Low:1.275

Shares:358.54M

Float Shares:275.05M

Volume Ratio:1.02

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.171

EPS(LYR):-0.114

ROE:-143.12%

ROA:-26.53%

PB:17.77

PE(LYR):-17.57

Loading ...

Overview Company News Filings

Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy

MT Newswires Live

Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says

MT Newswires Live

Imricor Medical Systems Q2 Loss Narrows, Revenue Down

MT Newswires Live

Imricor Medical Secures Second US Customer, Shares Up 3%

MT Newswires Live

Imricor Medical Systems - Anticipated FDA Clearances of Additional Capital Equipment Expected to Broaden Product Offering Available to U.S. Customers

THOMSON REUTERS

Imricor Says Philips Issues 'Third-Party Product Compatibility Declaration' for Its Interventional Magnetic Resonance Products

MT Newswires Live

Imricor Launches Cardiovascular Unit to Expand iMR Use in Cardiac Catheterization

MT Newswires Live

Imricor Medical Systems Hits 3-month High on Securing First US Hospital Customer

Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System

MT Newswires Live

Imricor Medical Systems, Inc-imricor Launches U.S. Commercial Operations

THOMSON REUTERS

Imricor Medical Systems Submits Steerable Introducers for US FDA Clearance

MT Newswires Live

Imricor Medical Systems, Inc-imricor Submits All Remaining 510(k) Devices to FDA

THOMSON REUTERS

Imricor Medical Systems - Submits Navtrac and Navtrac-mr Steerable Introducers for FDA 510(k) Clearance

THOMSON REUTERS

Imricor Medical Systems, Receives FDA 510(k) Clearance for Northstar Pediatric Label Expansion

Imricor Secures US FDA Clearance for Pediatric Expansion of NorthStar, Vision-MR Systems

MT Newswires Live

Imricor Medical Systems, - Receives FDA 510(k) Clearance for Vision-mr Diagnostic Catheter Pediatric Label Expansion

THOMSON REUTERS

Imricor Medical Systems Files US Registration Statement for About 39 Million Class A Shares

MT Newswires Live

BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review

Imricor Submits Third US FDA Premarket Approval Module for Vision-MR Ablation System

MT Newswires Live

Imricor Medical Systems, Inc-Submission of the Third Pma Module to the US FDA for Review

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":2.01,"timestamp":1787292720000,"preClose":2.05,"halted":0,"volume":415168,"delay":0,"changeRate":-0.019512195121951237,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":358542497,"eps":-0.17091670154876515,"marketStatus":"Market Closed","change":-0.04,"latestTime":"08-21 16:12:00 AEST","open":2.03,"high":2.03,"low":1.955,"amount":829322,"amplitude":0.036585,"askPrice":2.05,"askSize":10414,"bidPrice":1.96,"bidSize":41400,"shortable":3,"etf":0,"ttmEps":-0.17091670154876515,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":2.05,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.0159823998285065,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMR.AU","preClose":2.05,"auctionPrice":1.995,"auctionVolume":13919,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-26.53%","roe":"-143.12%","lyrEps":-0.114417,"volumeRatio":1.0159823998285065,"shares":358542497,"dividePrice":0,"high":2.03,"amplitude":0.036585,"preClose":2.05,"low":1.955,"week52Low":1.275,"pbRate":"17.77","psRate":"4301.44","week52High":2.25,"institutionHeld":0,"latestPrice":2.01,"committee":0.598024,"eps":-0.17091670154876515,"divideRate":0,"volume":415168,"delay":0,"ttmEps":-0.17091670154876515,"open":2.03,"prevYearClose":1.53,"prevWeekClose":2.04,"prevMonthClose":1.86,"prevQuarterClose":1.845,"fiveDayClose":2.04,"twentyDayClose":1.92,"sixtyDayClose":1.74,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786320000000,"name":null,"time":"","dateTimestamp":1786284000000,"actualEps":null},{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658918639","title":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658918639","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658918639?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:13","pubTimestamp":1786443206,"startTime":"0","endTime":"0","summary":"Jarden Research Adjusts Imricor Medical Systems' Price Target to AU$3.35 from AU$3.30, Keeps at Buy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7503","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658961945","title":"Imricor Medical Systems Nears 'Genuine Commercial Inflection Point' After Two Decades of Platform Development, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658961945","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658961945?lang=en_us&edition=fundamental","pubTime":"2026-08-11 12:50","pubTimestamp":1786423845,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) is nearing a \"genuine commercial inflection point\" as it transforms almost two decades of platform development into a recurring, high-margin revenue stream, Jarden sa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7503","IMR.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658604264","title":"Imricor Medical Systems Q2 Loss Narrows, Revenue Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2658604264","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658604264?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:50","pubTimestamp":1786333848,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems'  second-quarter net loss was $7.4 million, compared with $7.8 million in the prior-year quarter, according to a Monday Australian bourse filing.Revenue for the three months ended June 30 came in at $60,500, compared with $65,200 in the year-ago period, the medical device company said.The company said it is expanding its US commercial team, with additional hires to be added during the September and December quarters to cover new regions of the US.Imricor Medical Systems' shares rose nearly 3% in recent trading on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7503","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609876","title":"Imricor Medical Secures Second US Customer, Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609876","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658609876?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:34","pubTimestamp":1786325656,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  secured its second customer in the US, with Children's Medical Center, Dallas, in Texas purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.The hospital has an existing Philips magnetic resonance lab, which means no lab construction will be required, and procedures guided with the system can begin following installation. Children's Medical Center Dallas will launch a NorthStar-guided interventional magnetic resonance cardiac catheterization program.Its shares rose 3% in recent trading on Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658603967","title":"Imricor Medical Systems - Anticipated FDA Clearances of Additional Capital Equipment Expected to Broaden Product Offering Available to U.S. Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658603967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658603967?lang=en_us&edition=fundamental","pubTime":"2026-08-10 06:39","pubTimestamp":1786315198,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260809:nFWN44603C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7503","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644676","title":"Imricor Says Philips Issues 'Third-Party Product Compatibility Declaration' for Its Interventional Magnetic Resonance Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644676","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657644676?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:03","pubTimestamp":1786060983,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Philips Medical Systems Nederland issued a \"Third-Party Product Compatibility Declaration,\" covering Imricor's interventional magnetic resonance products when used with Philips' magnetic resonance systems, according to a Friday Australian bourse filing.This will allow Imricor's NorthStar mapping and guidance system to connect and operate in a commercial clinical setting with Philips magnetic resonance scanners.The declaration covers five initial magnetic resonance systems and four magnetic resonance system upgrades running software versions R12.1.1 or greater.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656895300","title":"Imricor Launches Cardiovascular Unit to Expand iMR Use in Cardiac Catheterization","url":"https://stock-news.laohu8.com/highlight/detail?id=2656895300","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656895300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:07","pubTimestamp":1785794846,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  launched Imricor Cardiovascular, a new business vertical designed to broaden the application of interventional magnetic resonance  in cardiac catheterization alongside its existing electrophysiology and ablation portfolio, according to a late Monday statement by the company.The platform enables US hospitals to perform radiation-free cardiac catheterization by integrating magnetic resonance imaging and catheterization into a single procedure.The approach is expected to shorten procedure time for each patient by around 35%, enhancing hospital efficiency while increasing available capacity in X-ray catheterization laboratories.The company said the technology particularly benefits pediatric and congenital heart patients by enabling repeated catheterizations without ionizing radiation while improving imaging and reducing anesthesia use.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","IMR.AU","CSII","BK4082","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654980830","title":"Imricor Medical Systems Hits 3-month High on Securing First US Hospital Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2654980830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654980830?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:15","pubTimestamp":1785114926,"startTime":"0","endTime":"0","summary":"BUZZ-Imricor Medical Systems hits 3-month high on securing first US hospital customer** Imricor Medical Systems'IMR.AXshares rise as much as 9.9% to A$2.11, highest level since April 23** Medical tech company launches U.S. commercial operations and secures first hospital customer** Rady Children's Hospital in San Diego will purchase Imricor's NorthStar iMR mapping and guidance system, becoming the company's first commercial customer in the U.S.** About 769,000 shares change hands, 2.1x the 30-day average volume** Including session moves, stock up 30.1% this year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4N43T02B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMR.AU","BK7007","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060709","title":"Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060709","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060709?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:18","pubTimestamp":1785111524,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  began its official US commercial launch, with the Rady Children's Hospital in San Diego, California, purchasing its NorthStar interventional magnetic resonance  mapping and guidance system, according to a Monday Australian bourse filing.It also launched a new vertical, Imricor Cardiovascular, for the NorthStar system. It expects to continue adding devices and applications within the Cardiovascular business over time.Several US hospitals are in the final stages of the purchasing process, the filing added. Revenue from the NorthStar sales is expected to exceed the European business' aggregate full-year revenue in 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067940","title":"Imricor Medical Systems, Inc-imricor Launches U.S. Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067940?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:34","pubTimestamp":1785105288,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nTUEBTLYG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7007","BK7503","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652226517","title":"Imricor Medical Systems Submits Steerable Introducers for US FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2652226517","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652226517?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:23","pubTimestamp":1784510608,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its NavTrac and NavTrac-MR steerable introducers for market clearance under the US Food and Drug Administration's 510 premarket notification pathway, according to a Monday filing with the Australian bourse.The devices are used to insert and guide a range of cardiovascular catheters into the heart during certain medical procedures, per the filing.Imricor said it has now completed 14 of the 15 FDA submissions required to establish a full product platform in the US.The company's shares gained 1% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","LABU","BK4588","BK4585","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652689642","title":"Imricor Medical Systems, Inc-imricor Submits All Remaining 510(k) Devices to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2652689642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652689642?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:25","pubTimestamp":1784503519,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nTUE9V0D1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7503","BK7508","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268961","title":"Imricor Medical Systems - Submits Navtrac and Navtrac-mr Steerable Introducers for FDA 510(k) Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268961?lang=en_us&edition=fundamental","pubTime":"2026-07-20 07:25","pubTimestamp":1784503519,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nTUE9V0D1F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648257852","title":"Imricor Medical Systems, Receives FDA 510(k) Clearance for Northstar Pediatric Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648257852","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648257852?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:29","pubTimestamp":1782955792,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems, Receives FDA 510 Clearance For Northstar Pediatric Label ExpansionJuly 2 -Imricor Medical Systems, IncIMR.AX:RECEIVES FDA 510 CLEARANCE FOR NORTHSTAR PEDIATRIC LABEL EXPANSIONRECEIVES FDA 510 CLEARANCE FOR VISION-MR DIAGNOSTIC CATHETER PEDIATRIC LABEL EXPANSIONCLEARED TO MARKET NORTHSTAR AND VISION-MR DIAGNOSTIC CATHETER FOR ALL AGES IN USFurther company coverage:IMR.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN433190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7503","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648613522","title":"Imricor Secures US FDA Clearance for Pediatric Expansion of NorthStar, Vision-MR Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2648613522","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648613522?lang=en_us&edition=fundamental","pubTime":"2026-07-02 07:24","pubTimestamp":1782948261,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  received US Food and Drug Administration  clearance to expand pediatric use of its NorthStar iMR navigation system and Vision-MR diagnostic catheter, according to a Thursday Australian bourse filing.The approvals permit both devices to be marketed to patients of all ages, including children and young adults, especially those receiving care at more than 250 children's hospitals across the US, per the filing.The company said its interventional magnetic resonance imaging approach may be beneficial in pediatric cardiology for congenital heart defects requiring repeated catheterizations, eliminating exposure to ionizing X-ray radiation.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK7007","IMR.AU","BK4585","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648524483","title":"Imricor Medical Systems, - Receives FDA 510(k) Clearance for Vision-mr Diagnostic Catheter Pediatric Label Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648524483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648524483?lang=en_us&edition=fundamental","pubTime":"2026-07-02 06:33","pubTimestamp":1782945213,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN433190:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","BK7007","IMR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646825833","title":"Imricor Medical Systems Files US Registration Statement for About 39 Million Class A Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646825833","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646825833?lang=en_us&edition=fundamental","pubTime":"2026-06-26 08:04","pubTimestamp":1782432292,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  filed a registration statement with the US Securities and Exchange Commission for 38.9 million class A common shares, according to a Friday notice on the Australian bourse.The shares are issuable under options the company previously granted as part of an equity incentive plan, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642477054","title":"BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2642477054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642477054?lang=en_us&edition=fundamental","pubTime":"2026-06-11 09:28","pubTimestamp":1781141339,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For ReviewJune 11  - Imricor Medical Systems, Inc IMR.AX:SUBMISSION OF THE THIRD PMA MODULE TO THE US FDA FOR REVIEWSUBMISSION INCLUDES VISION-MR ABLATION CATHETER 2, RF-5000 GENERATOR, RF-5000 TUBING SETFurther company coverage: IMR.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nTUEQP6L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","BK7508","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642741754","title":"Imricor Submits Third US FDA Premarket Approval Module for Vision-MR Ablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2642741754","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642741754?lang=en_us&edition=fundamental","pubTime":"2026-06-11 07:42","pubTimestamp":1781134928,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  has filed the third module of its premarket approval application with the US Food and Drug Administration , covering non-clinical bench testing for its Vision-MR Ablation Catheter 2.0, RF-5000 Ablation Generator, and irrigation tubing set, according to a Thursday Australian bourse filing.The submission contains testing data covering product performance, sterile shelf life, packaging integrity, software testing, electrical safety, electromagnetic compatibility, magnetic resonance safety, and usability, per the filing.The company is streamlining FDA approval via a modular review process while pursuing additional device clearances, with three products already cleared, including NorthStar, Vision-MR Diagnostic Catheter, and Vision-MR Diagnostic Catheter Cable, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7503","LABU","BK7508","IMR.AU","BK7007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642710424","title":"Imricor Medical Systems, Inc-Submission of the Third Pma Module to the US FDA for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2642710424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642710424?lang=en_us&edition=fundamental","pubTime":"2026-06-11 06:55","pubTimestamp":1781132143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nTUEQP6L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}